Physician profile
Brian Leonard Levy
NPI 1891813747
$416,593.64
in general payments reported to CMS, 2019-2025
6 companies · $33K in 2025
The $33K reported for 2025 was more than what 94% of Endocrinology, Diabetes & Metabolism providers received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $88K · 2020: $32K · 2021: $85K · 2022: $71K · 2023: $63K · 2024: $44K · 2025: $33K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $135K · Travel and Lodging: $3,933 · Food and Beverage: $947.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $135,452.50 |
| Travel and Lodging | $3,932.83 |
| Food and Beverage | $947.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $166,461.51 | 2020-2024 | Senza, Omnia |
| Cequr Corporation | $142,910.76 | 2022-2025 | Cequr Simplicity |
| Lifescan, INC. | $104,703.97 | 2019-2021 | |
| Globus Medical, INC. | $2,232.50 | 2025 | Senza |
| Stryker Corporation | $187.46 | 2023 | Ortholoc 3di |
| Dexcom, INC. | $97.44 | 2023 | Dexcom G6 Transmitter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Levy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.